Every year, roughly 800,000 people answer the call to donate blood, a selfless act with a profound ripple effect. But what truly happens to that precious gift after it leaves your arm? The journey is a race against time, a complex process unfolding within the walls of facilities like the NHS Blood and Transplant hub in Colindale.
Up to 2,000 bags of whole blood arrive daily, initiating a critical 27-hour window to process each donation. This isn’t simply about storage; it’s about preserving the life-saving potential within. Red blood cells, vital for trauma victims and surgical patients, are just one component carefully extracted.
But hidden within your donation lies something equally remarkable: plasma. This yellowish fluid, constituting 55% of your blood, is often called “liquid gold” for a reason. It’s brimming with antibodies, the building blocks for medicines that can dramatically improve – and even save – lives. The transformation, however, is far from immediate.
The process begins with filtration, meticulously removing white blood cells. Then, the blood is spun at incredible speeds within a powerful centrifuge. This separates the plasma from the red blood cells, a visual demonstration of the incredible components within a single donation.
Specialized presses then carefully divert each component into separate bags. The red blood cells are chilled to 4C, awaiting safety tests conducted in Bristol. Once cleared, a text message will inform you which hospital received your life-giving donation. Meanwhile, the plasma embarks on a different, even more frigid path.
Plasma destined for immediate use in treating severe bleeding is rapidly frozen to -20C. But a significant portion is sent to even colder depths – a staggering -40C – to become the foundation for groundbreaking new medicines. This requires specialized equipment and protective gear to shield workers from the intense cold.
This “liquid gold” is crucial for producing immunoglobulins, treating over 50 devastating autoimmune conditions, and albumins, essential for burn victims and those suffering traumatic injuries. Over 17,000 people in the UK rely on these plasma-derived medicines each year.
For 25 years, a ban stemming from concerns about ‘mad cow’s disease’ prevented the use of UK-sourced plasma for these medicines. That ban was lifted in 2021, and in March 2023, the first immunoglobulin created from a British donor was administered to an NHS patient – a landmark moment.
Currently, the UK lacks the infrastructure to fully process plasma into these vital medicines, necessitating shipment to Europe. While awaiting transport, the plasma is maintained at that bone-chilling -40C, a testament to the dedication required to preserve its potency.
Despite this reliance on European facilities, significant progress is being made. Since March 2023, thousands of vulnerable patients have benefited from medicines derived from British-donated plasma. However, the UK remains over 75% reliant on immunoglobulin from other countries.
Jan Majkowski, a key figure at the Colindale site, emphasizes the critical role of plasma. “The fractions of plasma are invaluable,” he explains. “They are critical in treating rare and common diseases, offering the only support for many patients.”
The NHS Blood and Transplant service is actively seeking more donors to achieve self-sufficiency, aligning with the government’s 10-Year Health Plan. This ambition aims to bolster the NHS’s resilience by reducing dependence on imported medicines.
Specialized plasma-only donation centers in Birmingham, Reading, and Twickenham allow donors to contribute more frequently. Beyond immunoglobulins and albumins, plasma yields vital clotting factors for bleeding disorders like haemophilia, and platelets crucial for cancer treatments.
The Colindale hub, staffed by 80 dedicated employees – many working through the night – tirelessly processes these components. Despite the current success, a shortfall of over 200,000 donors persists annually.
A particularly urgent need exists for more donors of Black heritage, as they are more likely to possess the Ro blood subtype, essential for treating sickle cell disorder, a condition prevalent within those communities. Every donation truly makes a difference, offering hope and healing to those in need.
